Feasibility of blood conservation strategies in pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension

Interactive Cardiovascular and Thoracic Surgery

Volumn 13, Issue 1, 2011, Pages 35-39

  Mcrae, Karen ^a   Shargall, Yaron ^a   Ma, Martin ^a   Thenganatt, John ^a   Slinger, Peter ^a   Granton, John T ^a   de Perrot, Marc ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Pulmonary endarterectomy; Pulmonary thromboendarterectomy; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ENDOTHELIN RECEPTOR ANTAGONIST; FRESH FROZEN PLASMA; HEMOGLOBIN;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; BLOOD CONSERVATION; BLOOD SALVAGE; CARDIOPULMONARY BYPASS; CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEEP HYPOTHERMIC CIRCULATORY ARREST; ELECTIVE SURGERY; ENDARTERECTOMY; ERYTHROCYTE TRANSFUSION; FEASIBILITY STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIVER DYSFUNCTION; LUNG EDEMA; MALE; OUTCOME ASSESSMENT; PATIENT SAFETY; PEROPERATIVE CARE; PLASMA TRANSFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PULMONARY ENDARTERECTOMY; PULMONARY HYPERTENSION; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; ALGORITHMS; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CHRONIC DISEASE; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; ENDARTERECTOMY; FEASIBILITY STUDIES; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; ONTARIO; OPERATIVE BLOOD SALVAGE; PULMONARY ARTERY; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; TIME FACTORS; TREATMENT OUTCOME;

EID: 79959678374     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1510/icvts.2010.252767     Document Type: Article

References (9)

1. Jamieson SW, Kapelanski DP, Sakakibara N, Manecke GR, Thistlethwaite PA, Kerr KM, Channick RN, Fedullo PF, Auger WR. Pulmonary endarte rectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003;76:1457-1462.
2. Dartevelle P, Fadel E, Mussot S, Chapelier A, Herve P, de Perrot M, Cerrina J, Ladurie FL, Lehouerou D, Humbert M, Sitbon O, Simonneau G. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23:637-648.
3. Jamieson SW, Auger WR, Fedullo PF, Channick RN, Kriett JM, Tarazi RY, Moser KM. Experience and results with 150 pulmonary thromboendar terectomy operations over a 29 month period. J Thorac Cardiovasc Surg 1993;106:116-126.
4. Fergusson DA, Hébert PC, Mazer CD, Fremes S, MacAdams C, Murkin JM, Teoh K, Duke PC, Arellano R, Blajchman MA, Bussières JS, Côté D, Karski J, Martineau R, Robblee JA, Rodger M, Wells G, Clinch J, Pretorius R; BART Investigators. A comparison of aprotinin and lysine analogues in high risk cardiac surgery. N Engl J Med 2008;358:2319-2331.
5. Niwa H, Nara M, Kimura T, Chiba Y, Ihaya A, Morioka K, Uesaka T, Tsuda T, Muraoka R. Prolongation of total permissible circulatory arrest duration by deep hypothermic intermittent circulatory arrest. J Thorac Cardiovasc Surg 1998;116:163-170.
6. McCullough JN, Zhang N, Reich DL, Juvonen TS, Klein JJ, Spielvogel D, Ergin MA, Griepp RB. Cerebral metabolic suppression during hypother mic circulatory arrest in humans. Ann Thorac Surg 1999;67:1895-1899.
7. de Perrot M, Granton J, Fadel E. Pulmonary hypertension after pulmonary emboli: an underrecognized condition. CMAJ 2006;174:1706.
8. Bonderman D, Turecek PL, Jakowitsch J, Weltermann A, Adlbrecht C, Schneider B, Kneussl M, Rubin LJ, Kyrle PA, Klepetko W, Maurer G, Lang IM. High prevalence of elevated clotting factor VIII in chronic throm boembolic pulmonary hypertension. Thromb Haemost 2003;90:372-376.
9. Suntharalingam J, Goldsmith K, van Marion V, Long L, Treacy CM, Dudbridge F, Toshner MR, Pepke Zaba J, Eikenboom JC, Morrell NW. Fibrinogen A alpha Thr312Ala polymorphism is associated with chronic thromboembolic pulmonary hypertension. Eur Respir J 2008;31:736-741.